Daito Pharmaceutical (4577.T) Earnings Analysis

Daito Pharmaceutical (4577.T) next reports earnings on 2026-10-08. Trailing P/E 11.87.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4577.T next report earnings?

Next earnings date2026-10-08
Consensus EPS estimaten/a
Revenue estimate13.95B

4577.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-1030.96 JPYn/an/an/a
2026-04-1035.21 JPYn/an/an/a
2026-01-1418.08 JPYn/an/an/a
2025-10-1023.24 JPYn/an/an/a
2025-07-1122.88 JPYn/an/an/a
2025-04-1410.17 JPYn/an/an/a
2025-01-109.49 JPYn/an/an/a
2024-10-1140.41 JPYn/an/an/a

4577.T valuation and analyst view

Trailing P/E11.87
Trailing EPS109.4 JPY
Price / book0.70
Dividend yield3.13%
Market cap36.53B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Daito Pharmaceutical (4577.T)'s next earnings date?

Daito Pharmaceutical is next scheduled to report on 2026-10-08 and revenue estimate of 13.95B.

Did 4577.T beat earnings last quarter?

Consensus estimate data was not available for 4577.T's 2026-07-10 report.

What is 4577.T's current P/E ratio and EPS?

4577.T trades at a trailing P/E of 11.87 on trailing EPS of 109.39987540665882 JPY.

What do analysts rate 4577.T?

4577.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.